Psilocybin–the active ingredient naturally found in psychedelic magic mushrooms–is increasingly being used to help fight what is often called ‘treatment-resistant depression’ among other mental illnesses. COMPASS Pathways is one bold healthcare venture on a mission to fight human suffering at scale using a combination of a one-time psilocybin treatment, ongoing therapy and digital tools. To discuss this new direction for mental healthcare, we are joined by COMPASS Pathways Co-Founder and Chairman, George Goldsmith, as well as Ed Bolton, Creative Director of Brand in frog London. George and his team at COMPASS Pathways worked with frog to communicate their story and carve a new category for investors and patients alike.Brought to you by frog, a global creative consultancy. frog is part of Capgemini Invent. (https://www.frog.co)Find episode transcripts and relevant info (https://www.frog.co/designmind/design-mind-frogcast-ep-33-a-new-direction-for-mental-healthcare)Download the new frog report 'The Regenerative Compass' (https://go.frog.co/the-regenerative-compass)Learn more about the frog + COMPASS Pathways collaboration (https://www.frog.co/work/forging-a-new-path-for-mental-health)Visit COMPASS Pathways (https://compasspathways.com)Host/Writer: Elizabeth Wood, Editorial Director, frogResearch & Story Support: Camilla Brown, Senior Copyeditor, frogAudio Production: Richard Canham, Lizard Media (https://www.lizardmedia.co.uk)